Covered Call (20 Mar 15): CLDN $26.28

Buy (100) shares CLDN @ $26.28
Sell (1) May 15 30 C @ $10.30
Net Debit: $15.98   Return Assigned: 102.5%   (55 days)


Celladon (CLDN) is about to announce potentially pivotal trial results from a 250-patient heart-failure gene-therapy trial (CUPID-2) in April.